The Coronavirus Disease 2019 Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences in Participants Treated With Nirmatrelvir Plus Ritonavir Versus Untreated Controls.
Saved in:
| Title: | The Coronavirus Disease 2019 Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences in Participants Treated With Nirmatrelvir Plus Ritonavir Versus Untreated Controls. |
|---|---|
| Authors: | Pandit JA; Scripps Research Translational Institute, La Jolla, California, USA., Radin JM; Scripps Research Translational Institute, La Jolla, California, USA., Chiang DC; Scripps Research Translational Institute, La Jolla, California, USA., Spencer EG; Scripps Research Translational Institute, La Jolla, California, USA., Pawelek JB; Scripps Research Translational Institute, La Jolla, California, USA., Diwan M; Scripps Research Translational Institute, La Jolla, California, USA., Roumani L; eMed, Miami, Florida, USA., Mina MJ; eMed, Miami, Florida, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jul 05; Vol. 77 (1), pp. 25-31. |
| Publication Type: | Observational Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
